Piramal Pharma Limited announced that Ms. Nathalie Leitch has tendered her resignation from the position of Non-Executive, Non-Independent Director of the Company with immediate effect on account of other professional commitments.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
157.5 INR | +0.39% |
|
+1.46% | +13.45% |
05-14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
05-13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.45% | 2.49B | |
+54.61% | 811B | |
+43.82% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.89% | 246B | |
+2.49% | 225B | |
+12.77% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Piramal Pharma Limited Announces Resignation of Nathalie Leitch as Non-Executive, Non-Independent Director